Objective: To determine if repeat transobturator tape (TOT) is feasible after failed initial synthetic mid-urethral sling (MUS) for stress urinary incontinence, and to ascertain objective physician-determined outcome as well as subjective questionnaire-based outcome for this procedure. Patients and Methods: Between February 2005 and February 2008, a total of 21 patients underwent repeat TOT procedure after failed sling treatment. Initial sling procedures were all synthetic MUS, i.e. tension-free vaginal tape in 5 cases and TOT in 16 cases. Results: At a mean follow-up of 16 months, physician-determined cure was achieved in 55% of patients, improvement in 15% and failure in 30%. Outcome deduced from the International Consultation on Incontinence Questionnaire at a mean follow-up of 17 months showed 53% of patients to be cured and 5% of patients to be improved, but failure was noted in 42% of patients. Conclusions: Repeat TOT after failed synthetic MUS treatment is a feasible procedure with minor morbidity. Repeat TOT provides a reasonable physician-determined success rate, but a lower patient self-reported success rate can be deduced from questionnaires. The transobturator approach seems to show poorer outcomes than the retropubic approach in repeat sling surgery.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.